Teva Employs Brand-Like Patent Litigation To Retain Generic Zoloft Exclusivity
This article was originally published in The Pink Sheet Daily
Firm claims in multiple lawsuits that other generic manufacturers are violating patents related to the manufacturing process for sertraline.
You may also be interested in...
Pfizer counters with “authorized” generic through its Greenstone division.
Firm notes strong uptake of the product in 2006, as well as more than $400 million in Thalomid sales for the year during earnings call.
Agreements expand the firm’s position in the COPD space, while also entering obesity, diabetes and metabolic syndrome space.